Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Chung Ryul Oh"'
Autor:
Chung Ryul Oh, Sun-Young Kong, Hyeon-Su Im, Hwa Jung Kim, Min Kyeong Kim, Kyong-Ah Yoon, Eun-Hae Cho, Ja-Hyun Jang, Junnam Lee, Jihoon Kang, Sook Ryun Park, Baek-Yeol Ryoo
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-13 (2019)
Abstract Background Although sorafenib is the global standard first-line systemic treatment for unresectable hepatocellular carcinoma (HCC), it does not have reliable predictive or prognostic biomarkers. Circulating cell-free DNA (cfDNA) has shown pr
Externí odkaz:
https://doaj.org/article/d4b0634ea94245ef911858c5c705d2ab
Autor:
Junghwan Lee, Jinyoung Kim, Ha il Kim, Chung Ryul Oh, Sungim Choi, Soomin Noh, Hee Kyong Na, Hwoon-Yong Jung
Publikováno v:
Clinical Endoscopy, Vol 51, Iss 2, Pp 196-200 (2018)
A gastrocolocutaneous fistula is a rare complication of percutaneous endoscopic gastrostomy (PEG). We report a case of a gastrocolocutaneous fistula presenting with intractable diarrhea and gastrostomy tube malfunction. A 62-year-old woman with a his
Externí odkaz:
https://doaj.org/article/6951d677850948aba8767d62f7be3410
Autor:
Changhoon Yoo1, Chung Ryul Oh1, Seung-Tae Kim2, Woo Kyun Bae3, Hye-Jin Choi4, Do-Youn Oh5, Myung-Ah Lee6 angelamd@catholic.ac.kr, Baek-Yeol Ryoo1 ryooby@amc.seoul.kr
Publikováno v:
Cancer Research & Treatment. Apr2021, Vol. 53 Issue 2, p291-300. 10p.
Autor:
Chung Ryul Oh, Woo Kyun Bae, Myung Ah Lee, Hye Jin Choi, Baek Yeol Ryoo, Changhoon Yoo, Seung Tae Kim, Do Youn Oh
Publikováno v:
Cancer Research and Treatment : Official Journal of Korean Cancer Association
Neuroendocrine tumors (NETs) are a group of malignancies arising from neuroendocrine cells and frequently originate in the gastrointestinal tract and pancreas. Although curative resection is the main treatment for localized disease, systemic therapy
Autor:
Chung Ryul, Oh, Jeong Eun, Kim, Yong Sang, Hong, Sun Young, Kim, Joong Bae, Ahn, Ji Yeon, Baek, Myung-Ah, Lee, Myoung Joo, Kang, Sang Hee, Cho, Seung-Hoon, Beom, Tae Won, Kim
Publikováno v:
International journal of cancerREFERENCES. 150(12)
The aim of our study is to evaluate the clinical efficacy of durvalumab in patients with microsatellite instability-high/mismatch repair-deficient (MSI-H/dMMR) or polymerase epsilon (POLE)-mutated metastatic or unresectable colorectal cancer (mCRC) w
Autor:
Chung Ryul Oh, Eo Jin Kim, Heejung Chae, Young Soo Park, Min-Hee Ryu, Hyung-Don Kim, Yoon-Koo Kang
Publikováno v:
Journal of Clinical Oncology. 41:461-461
461 Background: In localized gastric cancer (GC), deficient mismatch repair (dMMR) tumors reportedly have a favorable prognosis. However, a potentially detrimental effect of the dMMR status was suggested in patients treated with adjuvant chemotherapy
Autor:
Chung Ryul Oh, Heung-Moon Chang, Changhoon Yoo, Hyung-Don Kim, Kyu-Pyo Kim, Yeon-Mi Ryu, Jae Ho Jeong, Danbee Kim, Da Sol Lee, Baek-Yeol Ryoo, Seonmin Lee, Sang-Yeob Kim, Miyeon Kim
BackgroundWe evaluated the clinical implications of epithelial–mesenchymal transition (EMT) markers and peritumoral immune cell infiltration in patients with biliary tract cancer (BTC) treated with gemcitabine plus cisplatin (GemCis).MethodsForty-f
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ba912c16b9b7e6a26560250cb24b95f8
https://doi.org/10.21203/rs.3.rs-948152/v2
https://doi.org/10.21203/rs.3.rs-948152/v2
Autor:
Junnam Lee, Hwa Jung Kim, Sun-Young Kong, Min Kyeong Kim, Baek-Yeol Ryoo, Hyeon-Su Im, Jihoon Kang, Eun-Hae Cho, Ja-Hyun Jang, Chung Ryul Oh, Kyong-Ah Yoon, Sook Ryun Park
Publikováno v:
BMC Cancer, Vol 19, Iss 1, Pp 1-13 (2019)
BMC Cancer
BMC Cancer
Background Although sorafenib is the global standard first-line systemic treatment for unresectable hepatocellular carcinoma (HCC), it does not have reliable predictive or prognostic biomarkers. Circulating cell-free DNA (cfDNA) has shown promise as
Autor:
Hyo Song Kim, Jee Hung Kim, Jeong Eun Kim, Jin-Hee Ahn, Jung Yong Hong, Chung Ryul Oh, Ji Sung Lee, Tae Won Kim
Publikováno v:
Targeted oncology. 15(4)
Pazopanib is the only tyrosine kinase inhibitor approved for the treatment of patients with advanced soft tissue sarcoma (STS) who have received prior chemotherapy, but there have been limited real-world data on pazopanib for the treatment of advance
Autor:
Kyu-Pyo Kim, Sun Young Kim, Chang Sik Yu, Se Jin Jang, Jihun Kim, Jihoon Kang, Chung Ryul Oh, Jeong Eun Kim, Yong Sang Hong, Jin Cheon Kim, Tae Won Kim, Seok-Byung Lim
Publikováno v:
Clinical Colorectal Cancer. 17:e679-e685
Background We investigated whether the microsatellite instability (MSI) status affects the survival outcomes in patients with stage II/III rectal cancer who have undergone an upfront curative resection. Patients and Methods A total of 1103 patients w